Cargando…
Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors
The vast majority of patients with acute myeloid leukemia (AML) achieve complete remission (CR) after standard induction chemotherapy. However, the majority subsequently relapse and die of the disease. A leukemia stem cell (LSC) paradigm has been invoked to explain this failure of CR to reliably tra...
Autores principales: | Venton, G, Pérez-Alea, M, Baier, C, Fournet, G, Quash, G, Labiad, Y, Martin, G, Sanderson, F, Poullin, P, Suchon, P, Farnault, L, Nguyen, C, Brunet, C, Ceylan, I, Costello, R T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056970/ https://www.ncbi.nlm.nih.gov/pubmed/27611922 http://dx.doi.org/10.1038/bcj.2016.78 |
Ejemplares similares
-
Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer
por: Rebollido-Rios, Rocio, et al.
Publicado: (2020) -
Sepsis and neutropenia in hematological malignancies
por: Labiad, Y, et al.
Publicado: (2014) -
A red-shifted fluorescent substrate for aldehyde dehydrogenase
por: Minn, Il, et al.
Publicado: (2014) -
The contribution of single-cell analysis of acute leukemia in the therapeutic strategy
por: Madaci, Lamia, et al.
Publicado: (2021) -
Impact of Next-Generation Sequencing in Diagnosis, Prognosis and Therapeutic Management of Acute Myeloid Leukemia/Myelodysplastic Neoplasms
por: Madaci, Lamia, et al.
Publicado: (2023)